RA | RITUXAN® (rituximab) Infusions & Dosing Schedule
Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA study | BMC Musculoskeletal Disorders | Full Text
Rituximab in MS | Experimental MS Treatments | Multiple Sclerosis News Today
Rituximab Biosimilar Truxima Now Available for Rheumatoid Arthritis - MPR
RA | RITUXAN® (rituximab) Infusion Steps & Resources
Ultra-low doses of rituximab for continued treatment of rheumatoid arthritis (REDO study): a randomised controlled non-inferiority trial - The Lancet Rheumatology
Rituxan (Rituximab): Uses, Dosage, Side Effects, Interactions, Warning
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis | NEJM
Should You Get the COVID-19 Vaccine If You Take Rituximab?
Eficiency of Different Doses of Rituximab in Rheumatoid Arthritis | Reumatología Clínica
RA | RITUXAN® (rituximab) Dosing Overview for Rheumatoid Arthritis
Ultra-low doses of rituximab for continued treatment of rheumatoid arthritis (REDO study): a randomised controlled non-inferiority trial - The Lancet Rheumatology
Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study
PV | Taking & Dosing RITUXAN® (rituximab)
PV | RITUXAN® (rituximab) Dosing & Infusion Resources
Efficacy of Rituximab for Pemphigus: A Systematic Review and Meta-analysis of Different Regimens | HTML | Acta Dermato-Venereologica
Protocol of rituximab dosing and administration. | Download Scientific Diagram
Rituximab protocols | Download Table
Rituximab Infusion Dosing | RIABNI™ (rituximab-arrx)
GPA & MPA | Taking & Dosing RITUXAN® (rituximab)
Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis | SpringerLink
![European Medicines Agency approved rituximab dosing regimens [ 10 ] . | Download Table](https://www.researchgate.net/profile/Johannes-Schmidt-15/publication/259877472/figure/tbl1/AS:601669272346676@1520460541954/European-Medicines-Agency-approved-rituximab-dosing-regimens-10_Q640.jpg "European Medicines Agency approved rituximab dosing regimens [ 10 ] . | Download Table")
European Medicines Agency approved rituximab dosing regimens [ 10 ] . | Download Table
Lessons for rituximab therapy in patients with rheumatoid arthritis - The Lancet Rheumatology
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial - The Lancet
